Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Emerging immunotherapies for rheumatoid arthritis.

Reynolds G, Cooles FA, Isaacs JD, Hilkens CM.

Hum Vaccin Immunother. 2014;10(4):822-37. Epub 2014 Feb 17. Review.

2.

Novel immunotherapies for rheumatoid arthritis.

Richardson S, Isaacs J.

Clin Med (Lond). 2013 Aug;13(4):391-4. doi: 10.7861/clinmedicine.13-4-391. Review. No abstract available.

PMID:
23908512
3.

Biologic agents and immunotherapy in rheumatoid arthritis. Progress and perspective.

Wallis WJ, Furst DE, Strand V, Keystone E.

Rheum Dis Clin North Am. 1998 Aug;24(3):537-65. Review.

PMID:
9710886
4.

[Gene transfer immunotherapy in rheumatoid arthritis: perspectives].

Jorgensen C.

Rev Med Interne. 2001 Feb;22(2):163-71. Review. French.

PMID:
11234674
5.

Antigen-specific tolerogenic and immunomodulatory strategies for the treatment of autoimmune arthritis.

Satpute SR, Durai M, Moudgil KD.

Semin Arthritis Rheum. 2008 Dec;38(3):195-207. doi: 10.1016/j.semarthrit.2007.10.002. Epub 2008 Jan 4. Review.

6.

Therapeutic T-cell manipulation in rheumatoid arthritis: past, present and future.

Isaacs JD.

Rheumatology (Oxford). 2008 Oct;47(10):1461-8. doi: 10.1093/rheumatology/ken163. Epub 2008 May 25. Review.

PMID:
18503092
7.

Novel Immunotherapeutic Avenues for Rheumatoid Arthritis.

Semerano L, Minichiello E, Bessis N, Boissier MC.

Trends Mol Med. 2016 Mar;22(3):214-29. doi: 10.1016/j.molmed.2016.01.005. Epub 2016 Feb 12. Review.

PMID:
26875450
8.

The future of biologics in the treatment of rheumatoid arthritis.

Koopman WJ.

Semin Arthritis Rheum. 1994 Jun;23(6 Suppl 2):50-8. Review.

PMID:
7939732
9.

Modern techniques of immunomodulation in rheumatoid arthritis.

Codreanu C.

Roum Arch Microbiol Immunol. 1993 Jul-Sep;52(3):149-56. No abstract available.

PMID:
7833528
10.

Emerging biologic therapies in rheumatoid arthritis: cell targets and cytokines.

Singh R, Robinson DB, El-Gabalawy HS.

Curr Opin Rheumatol. 2005 May;17(3):274-9. Review.

PMID:
15838236
11.

Immunotherapy for rheumatoid arthritis.

Taylor PC, Williams RO, Maini RN.

Curr Opin Immunol. 2001 Oct;13(5):611-6. Review.

PMID:
11544014
12.

Immunological therapies for rheumatoid arthritis.

Edwards CJ.

Br Med Bull. 2005 Sep 20;73-74:71-82. Print 2005. Review.

PMID:
16174791
13.

Current immunotherapy in rheumatoid arthritis.

Meier FM, Frerix M, Hermann W, Müller-Ladner U.

Immunotherapy. 2013 Sep;5(9):955-74. doi: 10.2217/imt.13.94. Review.

14.

Molecular targets in immune-mediated diseases: focus on rheumatoid arthritis.

Cook AD, Visvanathan K.

Expert Opin Ther Targets. 2004 Oct;8(5):375-90. Review.

PMID:
15469389
15.

[Immunotherapy in rheumatoid arthritis; current status].

Breedveld FC, van de Putte LB.

Ned Tijdschr Geneeskd. 1996 Jun 15;140(24):1255-9. Review. Dutch. No abstract available.

PMID:
8700279
16.

Immunopathogenesis and immunotherapy in rheumatoid arthritis: an area in transition.

Klareskog L, Rönnelid J, Holm G.

J Intern Med. 1995 Sep;238(3):191-206. Review.

PMID:
7673848
17.

Regulation of TNF-α with a focus on rheumatoid arthritis.

Moelants EA, Mortier A, Van Damme J, Proost P.

Immunol Cell Biol. 2013 Jul;91(6):393-401. doi: 10.1038/icb.2013.15. Epub 2013 Apr 30. Review.

PMID:
23628802
18.

Prospects of immunotherapy for rheumatoid arthritis.

t Hart BA, Otten HG.

Pharm World Sci. 1995 Nov 24;17(6):178-85. Review.

PMID:
8597773
19.
20.

Tocilizumab, a humanized anti-IL-6R antibody, as an emerging therapeutic option for rheumatoid arthritis: molecular and cellular mechanistic insights.

Hashizume M, Tan SL, Takano J, Ohsawa K, Hasada I, Hanasaki A, Ito I, Mihara M, Nishida K.

Int Rev Immunol. 2015 May;34(3):265-79. doi: 10.3109/08830185.2014.938325. Epub 2014 Aug 6. Review.

PMID:
25099958

Supplemental Content

Support Center